GeoPharma Announces First Quarter End Call

Monday, August 13, 2007 General News J E 4
LARGO, Fla., Aug. 13 GeoPharma, Inc.(Nasdaq: GORX) announced today that it will host a conference call to discussresults for the first fiscal quarter ended June 30, 2007 on Tuesday, August14, 2007 at 11:30 a.m. (ET) with CEO, Mihir Taneja and VP/CFO, Carol Dore-Falcone. Participants may dial into the conference call 5 minutes before, or11:25 a.m. The dial in number for participants is 1-800-591-6930, passcode26667186. The Company will release the Company's operating results beforetrading the day of the call. Conference call replay will be available bydialing 1-888-286-8010 passcode 33122120 on August 14, 2007 at 1:30 p.m.through August 21, 2007.

GeoPharma, Inc. is a rapidly growing pharmaceutical company specializingin the manufacturing and distribution of over-the-counter, nutritional,generic drug and functional food products. The company's growth strategy is tocapitalize on its manufacturing expertise to develop high margin generic ornovel drugs for niche markets with high barriers to entry. GeoPharma'scompetitive advantage lies in its ability to circumvent or overcome thechallenges in these markets. For more about GeoPharma, Inc., go to ourwebsites at, and .

This press release may contain statements, which constitute forward-looking statements within the meaning of the Private Securities LitigationReform Act of 1995, including those regarding the company and itssubsidiaries' expectations, intentions, strategies and beliefs pertaining tofuture performance. All statements contained herein are based upon informationavailable to the company's management as of the date hereof, and actualresults may vary based upon future events, both within and withoutmanagement's control. Important factors that could cause such differences aredescribed in the company's periodic filings with the Securities and ExchangeCommission.

SOURCE GeoPharma, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
GeoPharma Announces Shareholder Approval of Merger...
Tutogen Medical, Inc. Reports Financial Results fo...